China Airlines has partnered with Tokyo restaurant Toutouan to offer Premium Business and Business Class passengers “natural style” Japanese cuisine on all its Japan routes.
Passengers flying Premium Business and Business Class on China Airlines’ flagship Japan routes will be able to enjoy Japanese in-flight cuisine created by Araki Hironaka, the head chef of Toutouan in Tokyo, and Toutouan Taipei’s head chef Wei-Ting Chen.
The first offering will be the “Imperial Cuisine of Early Spring” with Teriyayki Wagyu Beef as the main dish.
The menu will change to reflect main dishes made with seasonal ingredients.
The food will be served on new Japanese tableware by JIA.
JIA is the preferred supplier to many Michelin-starred restaurants and 5-star hotels worldwide and has won numerous international design awards. Additionally, notable institutions, including the UK's Victoria & Albert Museum and Wallpaper magazine, have praised its designs.
The containers themselves are produced using recycled materials that have received international certification and have at least a 70 percent reduction in carbon emissions during production.


Columbia Student Mahmoud Khalil Fights Arrest as Deportation Case Moves to New Jersey
Asian Currencies Mixed as Dollar Holds Firm Ahead of Jackson Hole
Why financial hardship is more likely if you’re disabled or sick
Gold Prices Hover Near Three-Month High as Oil, Treasury Yields Fall
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China
Shein Hong Kong IPO to Raise $1.7 Billion at $26.5 Billion Valuation
The pandemic is still disrupting young people’s careers
6 simple questions to tell if a ‘finfluencer’ is more flash than cash
Tokio Marine Eyes Multibillion-Dollar Suncorp Takeover
US-Canada Tariff War Escalates With 50% Auto Duties
Asian Currencies Mixed as Aussie Dollar Rises on Hot Inflation
Trump Buys SpaceX Shares After Record IPO
Trump Escalates Canada Trade War With 50% Tariffs
US Dollar Rises as Inflation Backs Fed Pause, Canadian Dollar Slides
US Stocks Finish Flat as Inflation Data, Nvidia Earnings Keep Investors Cautious
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim 



